Reecha SHARMA,Robert B. STAGG,Zhong WANG,Betzi ZAFRA,Lee Ming BOO,Assaf GOVARI,Thomas V. SELKEE,Christopher Thomas BEECKLER,Andres Claudio ALTMANN,Joseph Thomas KEYES,Athanassios PAPAIOANNOU,Kristine
申请号：
US16866401
公开号：
US20200305952A1
申请日:
2020.05.04
申请国别(地区):
US
年份:
2020
代理人:
摘要：
An ablation catheter system for drug refractory symptomatic paroxysmal atrial fibrillation (PAF). The system can include an elongated body； an electrode assembly comprising a shell configured with an inner chamber and a wall defining a proximal portion and a distal portion, the wall of the distal portion having at least one aperture； and a micro-element extending through the inner chamber between the proximal portion and the distal portion, the micro-element having a distal end received in the at least one aperture, the distal end being at least coextensive with an outer surface of the wall. The system is configured to achieve acute procedural PVI success for all patients of a predetermined patient population suffering from PAF.
